welcome
Investor's Business Daily

Investor's Business Daily

Business

Business & Economics

Biotech stock Zai Lab slips as investors digest mixed fourth-quarter report

Investor's Business Daily
Summary
Nutrition label

63% Informative

Biotech stock Zai Lab (ZLAB) slipped as investors digested the company's mixed fourth-quarter earnings report early Thursday .

The stock is approaching a buy point.

Zai lab posted a larger-than-expected loss, although smaller than in the year-ago quarter .

VR Score

65

Informative language

70

Neutral language

56

Article tone

formal

Language

English

Language complexity

23

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links